My posts and articles here are strictly personal, not reflective of positions or policies of Insilico Medicine, which disclaims any responsibility for my individual statements.

I am also 100% focused on extending healthy, productive life for everyone on the planet. Any kind of war is against my religion, and I can not support any kind of war, military action, or institution. I believe that countries and people need to work together to fight diseases and make the world more sustainable.

In 2014, I founded Insilico Medicine (www.insilico.com) a global clinical-stage generative AI drug discovery. Until 2019, it was an AI-first drug discovery company, with most of the team focused exclusively on developing and applying deep learning methods to drug discovery. Insilico is the original inventor of multiple drug discovery technologies with multiple granted and pending patents in biomarker development and generative chemistry and generative biology. In 2019 the company started working on its own therapeutic programs focusing predominantly on immunology, oncology, fibrosis, and CNS. It also made its industrial-strength target discovery platforms (PandaOmics) and generative chemistry (Chemistry42) platforms available for licensing and partnering. It raised over $400 million from expert healthcare, biotechnology, and technology investors, and entered 2 Phase II clinical trials with the novel target discovered using AI and novel molecule designed using AI. Since 2019, Insilico nominated 18 preclinical candidates and started 6 clinical trials.

I also founded, co-chair and personally sponsor the largest global non-profit conference on aging research and drug discovery - Aging Research and Drug Discovery (ARDD), www.AgingPharma.org. In 2024, the University of Copenhagen will host 11th annual ARDD - please register early as it usually sells out in advance.